<![CDATA[Optimal Sequencing of Bispecific Antibodies and CAR T Cells Remains Unclear]]>

Bispecific AntibodiesCAR T-cell therapyNeutral

AI Analysis

Summary

Megan Melody, MD, discusses the lack of clarity regarding optimal sequencing of bispecific antibodies and CAR T-cell therapy, noting it could take years before sufficient data emerges to guide clinical practice.

Importance:3/10

Sentiment:

0.00

bispecific antibodiesCAR T-cell therapytreatment sequencingclinical opinion

Read the original article

Published by Cancer Network on July 22, 2026 6:00 PM

Read Original